UPDATE : Tuesday, January 22, 2019
Shinpoong’s drug becomes first-line malaria treatment in Côte d'Ivoire
Korean drugmaker Shinpoong Pharm said Côte d'Ivoire listed the co...
by Park Gi-taek  |  2018-12-17 14:20
Celltrion Healthcare’s sell-off of domestic sales right raises window-dressing controversy
The Financial Supervisory Service has begun to inspect Celltrion Healthcare...
by Nam Doo-hyun  |  2018-12-17 12:48
Kyung Nam Pharm shareholders lambast delisting decision
The nation’s stock market operator said on Friday it decided to delist Kyun...
by Lee Hye-seon  |  2018-12-17 11:57
‘Global medical costs to keep rising in 2019’
Medical expenses around the world are expected to continue to rise next yea...
by Lee Min-ju  |  2018-12-14 15:42
Sanofi launches five P3 clinical trials for Hanmi’s diabetic drug
Hanmi Pharmaceutical said Friday that Sanofi, its global partner for efpegl...
by Lee Han-soo  |  2018-12-14 15:17
Robotic surgery experts gather in Seoul for conference
Experts in robotic surgery around the world have gathered at the Severance ...
by Lee Hye-seon  |  2018-12-14 15:16
New hepatitis C drugs compete in shrinking market
Despite the shrinking size of the hepatitis C treatment market with more pa...
by Nam Doo-hyun  |  2018-12-14 15:14
Government to strengthen management of drug-making plants overseas
The Ministry of Food and Drug Safety said Thursday that it has revised the ...
by Lee Han-soo  |  2018-12-13 16:01
Korea to allow fast-track review for innovative medical technologies
The government said it would introduce a fast-track evaluation procedure fo...
by Kwak Sung-sun  |  2018-12-13 15:44
88,000 X-ray devices used at 37,000 institutions in Korea
About 37,000 medical institutions were using 88,000 X-ray devices in Korea,...
by Kwak Sung-sun  |  2018-12-13 15:39
Danish Santa makes surprise visit at Severance Children’s Hospital
Denmark Ambassador to Korea Thomas Lehmann and some employees of Novo Nordi...
by Lee Han-soo  |  2018-12-13 15:34
Samsung BioLogics’ market cap rises after accounting issue
Samsung BioLogics is still showing its robust status in the Korean stock ma...
by Nam Doo-hyun  |  2018-12-13 15:33
Change in animal test heightens possibilities of developing dementia drugs
Startups can succeed in researching and developing new products but often e...
by Song Soo-youn  |  2018-12-13 15:28
Thyroid surgeries decline after overdiagnosis controversy
Thyroid surgeries have steadily fallen in the past five years after experts...
by Song Soo-youn  |  2018-12-13 11:52
Yuyu unveils new osteoporosis treatment
Yuyu Pharmaceutical said Thursday that it has launched Bazestar, a compound...
by Lee Han-soo  |  2018-12-13 11:50
SK, Sanofi begins P1 clinical trials for next-gen pneumococcal vaccine
SK Bioscience and Sanofi have started to conduct the U.S. phase 1 clinical ...
by Lee Han-soo  |  2018-12-12 17:22
Dong-A ST, Eugene Bell Foundation to supply tuberculosis drug to NK
Dong-A ST said Wednesday that it has signed sponsorship agreement with Euge...
by Lee Han-soo  |  2018-12-12 17:20
SMC continues to fight against ministry over MERS damage claim
Samsung Medical Center (SMC) and the Ministry of Health and Welfare are res...
by Choi Gwang-seok  |  2018-12-12 17:20
‘Bispecific antibody market offers promising outlook’
The treatment market using bispecific antibodies is likely to grow rapidly,...
by Nam Doo-hyun  |  2018-12-12 16:27
Samsung BioLogics, Celltrion shares soar despite uncertainty
The share prices of Samsung BioLogics and Celltrion rose Wednesday even tho...
by Lee Han-soo  |  2018-12-12 16:27
Back to Top